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THE ability of metal chelates derived from copper and dimethylglyoxime or
platinum, palladium and 6-mercaptopurine to inhibit the growth of tumour cells
has been demonstrated by Takamiya (1960) and Kirschner, Yung-Kang Wei and
Francis (1962) respectively. Further, Lenta and Riehl (1960) have demonstrated
the ability of metal chelates derived from ethylene diamine tetraacetic acid
(E.D.T.A.) to influence oxidative processes in liver mitochondria isolated from
the mouse hepatoma 98/15. Consequently, it seemed likely that other types
of metal chelate would have similar actions, especially those derived from the
transition metals, Ru, Os, Ni, Fe, Cu, Co, Zn, Cd, and Mn, and substituted 1,10-
phenanthroline or related bases, since these substances have been shown to exert
marked effects on a wide variety of biological systems including HeLa cells in
culture (White, Harris and Shulman, 1963; Shulman and Dwyer, 1964).
The present work reports the effect ofthe following three metal chelates on the
growth of the Landschutz ascites tumour in B alb C+ male or C female mice.
(a) bis (3,4,7,8-tetramethyl-1,10-phenanthroline) copper (II) dichloride, called
here Cu 1.
(b) tris(3,4,7,8-tetramethyl-1,10-phenanthroline)ruthenium (II) dichloride,
called here Ru 2.
(c) acetylacetonatobis (3,4,7,8-tetramethyl-1,10-phenathroline) ruthenium (II)
chloride, called here Ru 1.
The marked stability of cations like Ru 2, both to chemical treatment and
under biological conditions, suggests that their biological effects are due to the
cation as a whole and not to its constituents, the metal and the ligand (Koch,
Rogers, Dwyer and Gyarfas, 1957). While it is likely that Cu 1 also acts as the
cation, it is possible, since its stability is lower than that of Ru 2, that the consti-
tuents of Cu 1 also contribute to its biological action. Further ternary chelates,
formed from these constituents and physiological ligands or metals, could likewise
contribute to these biological effects (Shulman and Dwyer, 1964). Since stable
coordinately-saturated metal chelates are unable to form covalent bonds, their
biological actions must be mediated by physical means following their attachment
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to complementary biological surfaces by electrostatic and/or van der Waals's
forces. The physico-chemical properties of such chelates and the mechanisms
whereby they may produce their biological effects have been discussed in detail
by Brandt, Dwyer and Gyarfas (1954), Dwyer (1959) and Shulman and Dwyer
(1964).
In vivo treatment of Landschiitz ascites tumour
Groups of five B alb C+ S or Y mice, 6 to 7 weeks old, were inoculated intra-
peritoneally with 2-0 x 106 seven-days-old Landschutz ascites tumour cells. A
single dose of the appropriate chelate in aqueous solution was administered intra-
peritoneally on the following day and, in most cases, at daily intervals thereafter
for four successive days ; a 25 g. mouse received the required dose in 0 5 ml.
In each case, the highest dose used was the greatest tolerated with minimal
toxicity on repeated administration.
The animals were killed seven days after tumour inoculation and the tumour
cells removed from the peritoneal cavity by repeated washing with sterile saline.
The total number of cells present per animal was determined and the T/C value
calculated, i.e. the ratio of the mean number of cells present in the treated mice
to that in the controls.
The doses and number of animals used, their changes in weight, and the T/C
values are given in Table I.
TABLE I.-Effect of Cu and Ru Chelates on Landschutz Ascites Tumour
Growth in the Mouse
Number of AMean weight
Compound Dose daily Numnber of change Tumour growth
(in water) (mg./kg-) doses mice (g./mouse) (T/C)
(0 3 to 0 5 ml.
Controls water/mouse) I to 4 40
Cu1. 5 1 10 -1 . 005
2 10 -1 0 04
3 10 2 0 03
4 - 5 -2 0 03
Ru1. 10 1 -1 . 0 43
2 5 -2 0-13
3 5 -2 0 34
4 5 -3 019
Ru 2. 35 1 . +1 108
4 1 20 +1 0-76
4-5 1 10 +1 . 0 54
5 1 15 . 0 0-12
2 . 5 . -1 . 0 04
3 5 -1 . 0 04
4 5 -3 . 0 03
Control animals usually showed a small gain in weight seven days after tumour
inoculation when between 2 and 3 x 108 tumour cells per animal were present.
A single dose of Cu 1 (5 mg./kg.), Ru 1 (10 mg./kg.) or Ru 2 (5 mg./kg.), caused
significant inhibition of tumour growth (P < 0.05). Inhibition was further
significantly increased (P < 0 05) by repeated daily administration of Ru 1 and
Ru 2 but was near maximal with a single dose of Cu 1. While a single dose of
Cu 1 (5 mg./kg.) was more effective than a single dose of Ru 2 (5 mg./kg.) both
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were equally active following two consecutive administrations. On the other
hand, Ru 1, even at twice the dosage, was a considerably less active inhibitor of
tumour growth than either Ru 2 or Cu 1.
These results suggest that a single low dose of Cu 1 or two successive doses of
Ru 2 were sufficient to saturate adequately the sites of action of these drugs and
since such compounds are absorbed rapidly from the peritoneal cavity of normal
mice (Shulman and Dwyer, 1964) strong binding to such sites must also be rapid.
A comparable effect was not produced by Ru 1.
The action of Ru 2 was studied more extensively. It can be seen from Table
I that a single dose of 3-5 mg./kg. did not inhibit tumour growth, a dose of 4 0-
4-5 mg./kg. produced slight inhibition whereas 5-0 mg./kg. caused quite strong
inhibition without significant weight loss. Repeated doses of Ru 2, each 5 0
mg./kg., produced more marked inhibition but this was accompanied by weight
loss in each case. It may be seen from other weight changes (Table I) that all
doses ofCu 1 and Ru 1 which reduce the tumour cell count by at least 50% were
also slightly toxic to the animal.
There appears to be an association, in the case of Ru 2 and Cu 1, between
the toxicity of chelate to the tumour cell and to the host and it seems possible
that the chelate may initiate these different effects by a similar mechanism. The
same conclusion has been proposed with respect to the action of such chelates
on a number of physiological and microbiological systems and the apparently
steep dose/response relationship observed for Ru 2 in this experimental situation
has also been found in the other systems (Shulman and Dwyer, 1964). The situa-
tion is not as clear with Ru 1; its form oftoxicity in normal mice differs in many
respects from that shown by Ru 2 and it is probable that additional mechanisms
are involved (Shulman and Dwyer, 1964).
Since Ru 2 is a fluorescent compound its action on Landschutz ascites tumour
cells was studied by fluorescence microscopy. It was found that Ru 2 itself or
Ru 2 derivatives with components of the ascitic fluid could be observed on the
tumour cell surface 10 to 20 minutes after treatment and that within one hour
Ru 2 fluorescence could be detected intracellularly, in the mitochondria. These
results resemble in some respects those reported by Kornguth, Stahman and
Anderson (1961) using a fluorescent derivative of the basic polypeptide, poly-
lysine, and by Galbraith, Mayhew and Roe (1962) using gum tragacanth, and
they will be reported in full elsewhere.
The effect of chelate pre-treatment on the growth of Landschutz ascites tumour cells
in the mouse
In vitro pre-treatment ofascites tumour cells, followed by in vivo tumour assay,
was carried out using the Cu 1 chelate. Four ml. ofan 8-days-old ascites tumour
was removed from a single mouse and diluted 1 in 4 with physiological saline.
0A15 ml. quantities ofCu 1 in saline were added to 2 ml. aliquots ofdiluted tumour
cell suspension to give final chelate concentrations of2-6 X 10-4M and 6-5 X 10-5M.
An equivalent volume of saline was added to a further 2 ml. aliquot of diluted
ascites tumour cell suspension to serve as control, and all mixtures were incubated
at 370 C. for periods of 10 to 40 minutes. Following incubation, the treated
cells were washed several times with physiological saline to remove adsorbed
chelate and resuspended in physiological saline. In addition, one sample of cells
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incubated for 40 minutes with Cu 1 (6.5 X 10-5M) and others treated with chelate
(2.6 X 10-4M) for 10 minutes or 40 minutes remained unwashed.
Washed or unwashed, chelate treated or untreated ascites tumour cells were
then inoculated into groups of 5 mice (8 x 106 cells per mouse) and the tumour
cell counts made as before, 7 days later. The results are shown in Table II.
TABLE II.-Effect of Copper Chelate (Cu 1) Pre-treatment on Growth of
Landschiuz Ascites Tumour in the Mouse
Cell Tumour
Incubation treatment MIean weight growth
concentratioin Incubation after change inhibition
of Cu 1 time (min.) incubation (g./mouse) (T/C)
Washed or
Controls 40, 20 or 10 unwashed +3 to +4
6-5x 10-5Mu 40 washed +1 0 94
65x10-5M 40 unwashed +1 0 75
26x10-4M 10 washed . +1 0 21 2-6x10-4M 10 unwashed 1+ 0 09 2-6 x10-4M 20 washed 1+ 0 04
26x10-4M 40 washed 1+ <0*01
2 6x10-4M . 40 unwashed 0 <0-01
It may be seen that pre-incubation of Landschuitz ascites tumour cells with
the more concentrated solution of Cu 1 (2.6 x 10-4M) for 40 minutes completely
inhibited their growth, whereas pre-incubation for 10 or 20 minutes resulted in a
reduced although still marked effect. Tumour inhibition was slight at the lower
concentration of the chelate even following 40 minutes' pre-incubation. These
results support the suggestion that the dose/response relationship for chelate
inactivation of Landschutz ascites tumour cells is steep. Washing appeared
slightly to decrease the tumour inhibitory effect of Cu 1 in some cases.
Since the 40 minute period required for complete growth inhibition of the
tumour cells by Cu 1 coincides fairly closely with the time interval required for
the related Ru 2 chelate to penetrate the ascites tumour cell and become visibly
bound to the mitochondria, it is possible, assuming both substances act predo-
minantly in the form of the cation, that death of the cell results from bio-
chemical dysfunction which follows action of Cu 1 at mitochondrial and prob-
ably at other intracellular sites. Such a contention is supported by the ability
of metal chelates to penetrate isolated mitochondria (Koch and Gallacher, 1959)
and a number of intact mammalian and microbial cells with resultant depression
of the mechanisms associated with respiration (White, Harris and Shulman,
1963; Shulman and Dwyer, 1964), but does not exclude the possibility that the
events leading to tumour cell death may have been initiated or even well advanced
shortlv after adsorption of the chelate to the surface of the cell. It is possible
thatRu 2 may have been penetrating progressively to mitochondrial and other
intracellular sites in an effective concentration much more rapidly than was
apparent, since the effective concentration may be lower than that which is
adequate for Ru 2 detection by fluorescence microscopy.
The small but significant decrease (P < 0.05) occurring in the tumour inhibi-
tory action of Cu 1 when the tumour cells are washed with physiological saline
to remove adsorbed chelate (administered at the higher dose, 2-6 X 10-4M for
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10 minutes, Table II) suggests the probability that chelate association with
receptive sites on the surface of the tumour cell is a reversible process.
SUMMARY
Chelate cations derived from 3,4,7,8-tetramethyl-1,10-phenanthroline and
divalent copper and ruthenium inhibit the growth of Landschiitz ascites tumour
cells in the mouse. In the case of the copper compound such inhibition also
follows chelate pre-treatment of the tumour cells before their inoculation into the
host.
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